AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Glimtrol-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Ancerorn Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimtrol-M1 Tablet SR

DiaBeta-Duo SR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. DiaBeta-Duo SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, increasing risks of kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headaches, and tremors. Learn to recognize and address these symptoms; maintain regular meals and carry a rapid-acting glucose source like sugary snacks or juice. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Uses of Glimtrol-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimtrol-M1 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimtrol-M1 Tablet SR whole; do not crush, chew, or divide it. Administer this medication with food.

Common Side effects of Glimtrol-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimtrol-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimtrol-M1 Tablet SR whole; do not crush, chew, or break it. Administer this medicine with a meal.

How Glimtrol-M1 Tablet SR works:

Glimtrol-M1 SR tablets contain a dual-action antidiabetic formula: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimtrol-M1 Tablet SR and alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimtrol-M1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Sustained-release Glimtrol-M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimtrol-M1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Glimtrol-M1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimtrol-M1 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver dysfunction, initiate Glimtrol-M1 Tablet SR therapy at a reduced dosage; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimtrol-M1 Tablet SR :

Should you forget a Glimtrol-M1 Tablet SR dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimtrol-M1 Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimtrol-M1 Tablet SR

Retain this medication in its original, securely sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Glimtrol-M1 Tablet SR use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with impaired kidney function, the elderly, or those who consume significant quantities of alcohol. Symptoms can include muscle aches or weakness, vertigo, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Glimtrol-M1 Tablet SR and seek immediate medical attention.
Glimtrol-M1 SR tablets contain glimepiride and metformin, two medications combined to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when coupled with a healthy diet and consistent physical activity. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin reduces hepatic glucose production and improves cellular insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Glimtrol-M1 SR tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal discomfort, diarrhea, and headaches. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged Glimtrol-M1 Tablet SR administration can induce Vitamin B12 deficiency by impeding its gastrointestinal absorption. This deficiency, if left unaddressed, may lead to anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures proposed by some studies include annual supplemental Vitamin B12 intake.
Indeed, Glimtrol-M1 Tablet SR can induce hypoglycemia (low blood glucose). Nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor are indicative of this condition. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimtrol-M1 Tablet SR and alcohol is unsafe due to the risk of significantly reduced blood sugar (hypoglycemia) and a heightened probability of lactic acidosis.
Glimtrol-M1 Tablet SR
75
MRP 91
17% off